Primary Job Title Chief Strategy Officer Primary Organization HumanN
Gender Male
Investor Type Investor Stage Number of Exits
LinkedIn View on LinkedIn
Bril Flint is the Chief Strategy Officer at HumanN. He attended MIT Sloan School of Management.
Overview
Personal Investments
Announced Date | Organization Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|
 Rabbet | Angel Round - Rabbet | |||
 NuPark | Seed Round - NuPark | |||
 Recursion Pharmaceuticals | Debt Financing - Recursion Pharmaceuticals | |||
 Wonder Technologies | Seed Round - Wonder Technologies | |||
 JamHub | Series A - JamHub |
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Phunware |  Central Texas Angel Network | Series F - Phunware | |||
Phunware | Central Texas Angel Network | Series E - Phunware | |||
Phunware | Central Texas Angel Network | Series D - Phunware |
Exits
- Recursion Pharmaceuticals
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning. - NuPark
NuPark provides an enterprise system of record for parking operations.
Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
 EMI Music | |||
 Dell | |||
 Bain & Company |
Board and Advisor Roles
Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
 Appconomy |
Related Hubs
Education
Recent News and Activity
Rabbet raised from Bril Flint and 4 other investors
NuPark raised from Bril Flint and 2 other investors
Wonder Technologies raised from Bril Flint and 7 other investors
JamHub raised from Angel Investor Forum and 6 other investors
